Q1 FY2024 · Presentation
ATTRibute-CM Phase 3 trial and emerging real-world evidence in ATTR-CM · 22 pages
Read BridgeBio Pharma, Inc.'s results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional